ceronapril

Known as: 1-(6-amino-2-((hydroxy(4-phenylbutyl)phosphinyl)oxy)-1-oxohexyl)proline, ceranapril 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-1999
024619901999

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
The background for these investigations was the discovery that formation of angiotensin II by the renin angiotensin system can… (More)
Is this relevant?
1997
1997
1. The ability of 5-HT2 and 5-HT4 receptor antagonists to modify the disinhibitory profile of diazepam and other agents was… (More)
Is this relevant?
1996
1996
OBJECTIVE To assess the effect of the angiotensin-converting enzyme inhibitor ceronapril on cerebral blood flow (CBF) in patients… (More)
Is this relevant?
1993
1993
We profiled the concentrations of angiotensin I (Ang I), angiotensin II (Ang II), and angiotensin(1-7) [Ang(1-7)] by the… (More)
Is this relevant?
1993
1993
This pilot clinical trial was a 15-week, double-blind, controlled, three-way crossover study evaluating cognitive effects of… (More)
Is this relevant?
1993
1993
OBJECTIVE To investigate the effect of the new angiotensin converting enzyme inhibitor ceranapril (1 mg/kg) on the cerebral blood… (More)
Is this relevant?
1992
1992
In these studies, we have investigated possible cognition-enhancing effects of angiotensin-converting enzyme (ACE) inhibition… (More)
Is this relevant?
1992
1992
Three experiments that used a latent inhibition procedure to investigate the effects of ceronapril on attentional processes in… (More)
Is this relevant?
1992
1992
Lipophilicities of seven structurally diverse angiotensin-converting enzyme (ACE) inhibitors, viz., captopril, zofenoprilat… (More)
Is this relevant?
1992
1992
While it is known that randomly bred normotensive Wistar stock and hypertensive rats alter their alcohol consumption when… (More)
Is this relevant?